Physician

Robert J Olson, MD

According to 2025 Medicare claims, Robert Olson, MD (NPI: 1356320279) practices psychiatry in the Mankato, MN market, with the plurality of this provider's patient population coming from Blue Earth, MN. This provider's primary affiliated billing organization is MANKATO CLINIC LTD (NPI: 1629044029; TIN: 410849339) and primary practice location at 56001-4458. Olson is affiliated with the Stratum Med ACO (ACO ID: A4527), Mayo Clinic Community ACO, LLC (ACO ID: A4617), Aledade 103 Upper Midwest MSSP (ACO ID: A5003), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Olson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 242 traditional Medicare patients, billed 1,949 HCPCS/CPT codes, and received $116,042 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,386 prescription claims across 422 beneficiaries totaling $2,722,929 in drug costs, led by Austedo Xr (Deutetrabenazine). Open Payments data shows 15 records totaling $310. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,047,684 to $2,722,929. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	226	2,199	$97,810
2016	218	2,604	$92,260
2017	205	1,801	$81,444
2018	214	1,753	$80,434
2019	263	2,274	$109,007
2020	252	2,187	$107,261
2021	255	2,178	$115,383
2022	260	1,865	$94,606
2023	240	1,726	$87,889
2024	242	1,949	$116,042

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	316	6,619	$1,047,684
2016	342	7,039	$855,114
2017	330	7,445	$920,528
2018	369	8,203	$1,090,004
2019	386	8,862	$1,503,393
2020	374	9,628	$1,945,153
2021	415	10,464	$2,414,382
2022	416	11,203	$3,001,119
2023	419	11,278	$3,381,246
2024	422	11,386	$2,722,929

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	235	667	$85
90833	Psychotherapy with evaluation and management visit, 30 minutes	164	395	$51
80061	Blood test, lipids (cholesterol and triglycerides)	48	64	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	190	328	$11
36415	Insertion of needle into vein for collection of blood sample	55	131	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Austedo Xr	Deutetrabenazine	125	2,838	$757,560
Austedo	Deutetrabenazine	38	1,138	$381,626
Rexulti	Brexpiprazole	156	4,085	$202,364
Wakix	Pitolisant Hcl	12	360	$194,152
Vraylar	Cariprazine Hcl	108	3,380	$169,692

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$310	Supernus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert J. Olson, MD?

Tedicare shows public-source Medicare data for Robert J. Olson, MD (NPI 1356320279), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert J. Olson, MD have ACO affiliation data?

Robert J. Olson, MD is shown with ACO affiliation data for Stratum Med ACO (MSSP, ACO ID A4527), Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617), Aledade 103 Upper Midwest MSSP (MSSP, ACO ID A5003), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Robert J. Olson, MD?

Robert J. Olson, MD is linked to MANKATO CLINIC LTD (billing NPI 1629044029) in the available physician profile data.

Does Robert J. Olson, MD have Open Payments data?

Robert J. Olson, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.